Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 53 medicines
CBG-MEB · 44 medicines
MS · 24 medicines · Historical list
SFDA · 18 medicines · Historical list
AIFA · 17 medicines
ALIMS · 15 medicines
HSA · 12 medicines
FDA · 9 medicines
HALMED · 5 medicines
PHARMAC · 3 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
12 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Gabapentin | United States | 250MG/5ML | solution | Marketed | Rubicon Research |
| Gabapentin | United States | 100MG, 300MG, 400MG … | tablet | Marketed | Zydus Pharms USA INC |
| Gabapentin | United States | 100MG, 200MG, 300MG … | capsule | Marketed | Aurobindo Pharma |
| Neurontin | United States | 600MG, 800MG | tablet | Marketed | Viatris |
| Neurontin | United States | 100MG, 300MG, 400MG | capsule | Marketed | Viatris |
| Neurontin | United States | 250MG/5ML | solution | Marketed | Viatris |
| Gralise | United States | 300MG, 450MG, 600MG … | tablet | Marketed | Almatica |
| Relgaabi | United States | 100MG, 200MG, 300MG … | capsule | Marketed | Sciegen Pharms |
| Gaba 300-EZS | United States | Status unknown | |||
| Gabapentin Encarbil | United States | 300MG, 600MG | tablet, extended release | Tentative approval | Glenmark Pharms LTD |
| Gabapentin Enacarbil | United States | 600MG | tablet, extended release | Tentative approval | Annora Pharma Private Limited |
| Horizant | United States | 300MG, 600MG | tablet, extended release | Marketed | Azurity |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
Guidelines in the library that name this substance.
Recent articles that name this substance.
